Instructional Course Lectures, The American Academy of Orthopaedic Surgeons - Osteoporosis
- 1 April 1996
- journal article
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 78 (4) , 618-32
- https://doi.org/10.2106/00004623-199604000-00019
Abstract
Osteoporosis is characterized by decreased bone mass and increased susceptibility to fracture. Primary osteoporosis is defined as osteoporosis that occurs in an individual who has no endocrinopathy or other disease state that would account for the changes in bone mass. Osteoporosis affects 20 millioKeywords
This publication has 110 references indexed in Scilit:
- A 5‐year controlled randomized study of prevention of postmenopausal trabecular bone loss with nasal salmon calcitonin and calciumEuropean Journal of Clinical Investigation, 1994
- Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitoninJournal of Bone and Mineral Research, 1994
- One-year psoas training can prevent lumbar bone loss in postmenopausal women: A randomized controlled trialCalcified Tissue International, 1993
- Long-term thyroxine treatment and bone mineral densityThe Lancet, 1992
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 1990
- Hip Fracture and the Use of Estrogens in Postmenopausal WomenNew England Journal of Medicine, 1987
- BONE MASS IN POSTMENOPAUSAL WOMEN AFTER WITHDRAWAL OF OESTROGEN/GESTAGEN REPLACEMENT THERAPYThe Lancet, 1981
- CalcitoninNew England Journal of Medicine, 1981
- Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of EstrogenNew England Journal of Medicine, 1980